mTOR Complex 1 Content and Regulation Is Adapted to Animal Longevity

8Citations
Citations of this article
19Readers
Mendeley users who have this article in their library.

Abstract

Decreased content and activity of the mechanistic target of rapamycin (mTOR) signalling pathway, as well as the mTOR complex 1 (mTORC1) itself, are key traits for animal species and human longevity. Since mTORC1 acts as a master regulator of intracellular metabolism, it is responsible, at least in part, for the longevous phenotype. Conversely, increased content and activity of mTOR signalling and mTORC1 are hallmarks of ageing. Additionally, constitutive and aberrant activity of mTORC1 is also found in age-related diseases such as Alzheimer’s disease (AD) and cancer. The downstream processes regulated through this network are diverse, and depend upon nutrient availability. Hence, multiple nutritional strategies capable of regulating mTORC1 activity and, consequently, delaying the ageing process and the development of age-related diseases, are under continuous study. Among these, the restriction of calories is still the most studied and robust intervention capable of downregulating mTOR signalling and feasible for application in the human population.

Cite

CITATION STYLE

APA

Mota-Martorell, N., Jové, M., & Pamplona, R. (2022, August 1). mTOR Complex 1 Content and Regulation Is Adapted to Animal Longevity. International Journal of Molecular Sciences. MDPI. https://doi.org/10.3390/ijms23158747

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free